Leukemic cells from a patient with Ph-negative chronic myeloid leukemia (CML) had a normal karyotype. M-BCR was rearranged and chromosome in situ hybridization showed a n ABL insertion between 5' and 3' M-BCR on a n apparently normal chromosome 22. T h e association of 5' BCR and 3' ABL at t h e 5' junction of t h e chromosome 9 insert was typical of t h a t found for t h e BCR-ABL fusion g e n e in o t h e r patients with t h e standard t(9;22) and CML.
T fusion gene characterizes a diverse group of human leukemias, which are manifested as chronic myeloid leukemia (CML), acute lymphocytic leukemia, acute myeloid leukemia and essential thr~mbocythemia.'.~ The distinctive Ph chromosome is one product of a reciprocal translocation, t(9;22)(q34;qll): the vehicle that brings 3' exons and polyadenylation/termination sequences of the ABL oncogene from chromosome 9 to 5' regulatory promoter and exon sequences of the BCR gene on the derivative 22 or Ph chromosome. Formation and function of the BCR-ABL hybrid gene appears to be a fundamental step in the development of these l e~k e m i a s .~.~ Nowhere is this more striking than in CML, nearly all cases of which show the Ph chromosome. The existence of a small group of clinically and hematologically typical cases of C M L whose leukemic cells have no Ph chromosome and no apparent karyotypic change was a disturbing exception until it was shown that BCR and ABL were indeed associated, usually on chromosome 22.'s'3 These findings confirmed the importance of the BCR-ABL fusion gene but posed a question about the mechanism of movement of ABL from its usual place on chromosome 9 to chromosome 22, apparently without the aid of cytogenetic translocation.
Our earlier in situ hybridization and genetic studies of one 3' M-BCR was joined to a region of chromosome 9 q 3 4 rich in repetitive sequences and lying s o m e distance 3' of ABL.
T h e chromosome 9 insert was at least 329 kilobases long and included 3' ABL and a larger portion of chromosome 9q34. Our results allowed u s to exclude transposon-o r retroviral-mediated insertion of ABL into chromosome 22.
Instead, we favored a two-translocation model in which a second translocation reconstituted a standard t(9;22)(q34: qll) but left t h e chromosome 9 insert, including 3' ABL, in chromosome 22.
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of these patients had shown the insertion of a small part of chromosome 9, at least that part carrying the 3' ABL sequences having homology with v-abl, between the 5' and 3' sequences of the BCR gene on chromosome 22. The involved chromosome 22 appeared to be whole and morphologically normal. We report the results of our investigations of the size of this chromosome 9 insert within BCR, the nature of the breakpoint junctions, and the mechanism of ABL transposition.
MATERIALS AND METHODS

Previous Studies of Ph-Negative CML Patien1
Patient M.B., a 45-year-old white man, was diagnosed with CML in 1981 and died in myeloid blast crisis in March 1986. At diagnosis, he did not have the Ph chromosome which characterizes this leukemia and was karyotypically normal. Southern blot studies showed a rearrangement in M-BCR, and chromosome in situ hybridization analysis indicated insertion of ABL sequences into an otherwise normal chromosome 22." An interesting feature of this patient's leukemic cells, relevant to the understanding of data presented in this report, was the development, with the onset of blast crisis, of homozygosity for several gene sites, including IgCX, M-BCR-5' and M-BCR-3' on the abnormal chromosome 22. This finding suggested that the normal chromosome 22 homologue had been lost and replaced by a copy of the chromosome carrying the ABL insert.I4 Clinical, hematological, cytogenetic, and molecular features of patient M.B. have been described in detail else-0. I I. 14. I 5 and were summarized re~ently.~
Probes
The following molecular probes were used: M-bcr-u, a "universal" M-BCR probeI6; M-bcr-3', a 1.2-kilobase (kb) HindIII-BglII fragment from 3'M-BCR (probe 1, Oncogene Science, Manhasset, NY); M-bcr-5'. a 1.45-kb BglII-HindIII fragment from 5'M-BCR"; a 0.4-kb BamHI probe isolated from the 5' end of a cloned 3'M-BCR breakpoint fragment from patient M.B. and considered to derive from the 3' end of the chromosome 9 sequence inserted into chromosome 22 ( Fig 1B) ; ABL exon IB, a 1.2-kb KpnI-EcoRI fragment containing exon IB of the ABL gene (Groffen et al, unpublished observations); T-39-1-2, a 1 .O-kb EcoRI fragment containing chromosome 9 sequences immediately 3' to the translocation breakpoint in the CML cell line K562'*; T-39-2-2, a 1.4-kb EcoRI fragment representing the chromosome 9 translocation breakpoint from the DNA of a CML patient (not M.B.) (Groffen et 
Southern Blot Analysis
High-molecular-weight (mol wt) DNA was isolated from peripheral blood or bone marrow cells, digested with restriction enzymes according to the manufacturer's guidelines, electrophoresed on 0.8% agarose gels, and transferred to nitrocellulose (Schleicher and Schuell, Dassel, West Germany) or nylon membrane (Gene Screen Plus, New England Nuclear, Boston, MA) according to the method of Southern." Probes were isolated from plasmid in low-meltingpoint agarose (Bethesda Research Laboratories, Gaithersburg, MD), oligolabeled with '*P-dCTP (Amersham International, Amersham, UK), and hybridized to the filters overnight at 65OC. Probes contaminated with repeat sequences were prehybridized with driver DNA.20 Final posthybridization washes were in 0.3 x SSC, 0.1% sodium dodecyl sulfate (SDS), 0.1% sodium pyrophosphate at 65OC. Filters were exposed to Kodak XAR-2 or XAR-5 film for 1 to 5 days at -8OOC with intensifying screens.
Construction and Screening of a Genomic Library
DNA isolated from blast crisis leukemic cells of patient M.B. was digested with BgrII and electrophoresed in a 0.8% low-meltingtemperature agarose gel (BRL), and fragments in the size range of 7 to 20 kb were isolated and purified. 21 The DNA was ligated to the arms of the bacteriophage vector EMBL 3 (Clontech Laboratories, Palo Alto, CA), and packaged in vitro with the Gigapack Gold system of Stratagene (La Jolla, CA). Phage libraries were screened using nitrocellulose filters as described for Southern hybridization. Inserts from selected colonies were subcloned into pUC18 or pUC19 for restriction mapping.
Chromosome In Situ Hybridization
Metaphase cells were prepared from a normal male donor and from a male CML patient showing the Ph chromosome and the t(9;22)(q34;qll). A 0.4-kb BnmHI fragment (Fig lB) , subcloned into pUC19, was nick-translated with 3HdATP and 'HdCTP (Amersham) to a specific activity of 1 to 2 x lo7 cpm/pg and hybridized in situ to metaphase chromosomes as described.22 Sonicated total human DNA (2 mg/mL) was added to the hybridization mix to quench repetitive sequences in the probe."
Field Inversion Gel Electrophoresis ( F E E )
DNA of very high mol wt prepared from frozen cells of patient M.B. and a normal male control was digested in agarose plugs.z3 The plugs were placed in a 1% agarose gel and electrophoresed alongside mol wt markers of Sacchnromyces cerevisine chromosomes. After FIGE,23.24 the DNA was transferred to Gene Screen Plus membrane and hybridized with labeled probes. The filters were washed and sequentially rehybridized according to the manufacturer's recommendations.
RESULTS
Our earlier studies of leukemic cells from this Ph-negative CML patient indicated that a part of chromosome 9 carrying ABL sequences was inserted between 5' and 3' parts of BCR on chromosome 22 (Fig 1A) . The chromosome 9 fragment will have two breakpoints, a 5' breakpoint which we assume is adjacent to 5' sequences of M-BCR as has been demonstrated in other cases of CML: and a 3' breakpoint which will be associated with 3' sequences of M-BCR. We refer to these as the 5' and 3'junctions of the chromosome 9 insert.
We describe the isolation and study of the 3' junction.
Identification of a 3'M-BCR Rearranged Fragment
DNA isolated from leukemic blood sampled during terminal blast crisis was Southern blotted, and the filter was hybridized with M-bcr-u. Abnormal bands were detected in BglII and BamHI digests, and the germline 5.0-kb BgZII and 3.3-kb BamHI bands were absent (Fig 3) , consistent with our For personal use only. on September 24, 2017. by guest www.bloodjournal.org From O previously reported findings.'"'' M-bcr-u detects abnormal bands representing both the S'M-BCR/3'ARL breakpoint junction on the Ph chromosome. and the S'ARL/3'M-RCR junction on the 9q+ in leukemic DNA of CML patients carrying the standard t(9:22)." Independent hybridimtion of the M-bcr-S'and M-bcr-3' probes showed that the 9.5-kb &Ill and 3.8-kb BamHl bands represented 3' M-RCR breakpoint fragments in our patient's DNA (Fig 3) .
isolation of a Chimeric 9:22 Junction
A size-selected library of Bx/lI fragments in the range of 7 to IS kb was prepared. and approximately 1.7 x 106 recombinant phages were screened with M-bcr-u. yielding 3 1 positive colonies. All 31 cohybridized with the M-bcr-3' probe and were therefore presumed to derive from the 3' junction fragment.
Eight positively hybridizing phage colonies were subcloned and restriction mapped. All genomic inserts showed homology with a small region of M-RCR-3'. including the Hindlll&Ill region encompassed by the M-bcr-3' probe (Fig IR) , but diverged from normal M-RCR in the 8-kb region 5' of a Xho site (Fig 1 R) . These sequences represented the 5' part of the chimeric 3'junction fragment. We could not isolate a repeat-free probe from this region because of the large number of repeat sequences present; however. a 0.4-kb BanrHl fragment (Fig I R) provided a discrete signal after prehybridization with excess sonicated total human D N A x For This probe cohybridized to the 19-kb EcoRl and 9.5-kb RgllI fragments detected with M-bcr-3' in our patient's DNA and also detected the rearranged 6-kb Windlll fragment predicted by our restriction map (Figs IR and 3. data not shown). The 0.4-kb RantHl probe was hybridized in situ to normal metaphase chromosomes. Significant labeling on chromosome 9 a t band 9q34 (Table I ) 
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M-RCR-Y Reconthines With Seqt4ence.r Ourside and
Distantly 3' of the AUI. Gene on 9q34
FlGE and chromosome in situ hybriditation techniques were used to determine more precisely the origin of the 0.4-kb RamHl probe representing chromosome 9q34 sequences that had recombined with M-bcr-3' in our patient.
F E E analysis allows examination of the entire length of the ARL and RCR genes using two enzymes. Sorl and S/il. and appropriate ARL or RCR probes. and RCR probes used in this study (Fig 2A and R) . \Ye hybridited the 0.4-kb RamHl probe to FIGE-separated A'orl-. Sacll-. Sfil-. Mlul-. and U.r.rHII-restricted DWA from a normal donor. The probe did not hybriditc with any of the gcrmline-site A R L fragments detected by T-39-2-2 or ARL exon 111 probes when they were hybridited serially to the same membranes (Fig 4. data not shown) . The T-39-1-2 and ARL exon IR probes did hybriditc to similar-sited fragments in .Yo11 and Sacll digests but detected Sfil. MhI. R.r~tllI. and Nrul fragments of dimerent site than the 0.4-kb HanrHl probe (Fig 4, data not shown) . These results showed that the part of chromosome 9q34 that had recombined with IM-bcr-3' in the junction fragment was not part of the ARL gcnc.
The 0.4-kb BamHl probe specifically labeled the normal chromosome 9 at band q34 and the Ph chromosome in metaphase cells carrying a standard t(9;22) translocation. The 9q A chromosome showed no significant labeling (Table I ). This result Chromosome in sir11 hyhridii-arion analysis. For personal use only. on September 24, 2017. by guest www.bloodjournal.org From showed that the 0.4-kb BamHI fragment was contained within the region 3' ABL -9qter, which is translocated to the Ph chromosome as a result of the t(9;22). Because the 0.4-kb BamHI probe was not part of the ABL gene (FIGE results above), we concluded that it was located telomeric of ABL on 9q34.
At Least 300 kb of DNA From Chromosome 9 Is Inserted Into BCR on Chromosome 22
Probes from the 5' and 3' sides of the M-BCR breakpoint have been used to identify long-range restriction fragments originating from the Ph and 9q+ chromosome, respectively, in two C M L line^.^','^ We applied a similar approach to analysis of the 5' and 3' M-BCR breakpoint junctions in our patient. According to our model (Fig lA) , the M-bcr-5' probe will detect DNA fragments containing the 5' BCR/ ABL fusion gene (5' junction), whereas the M-bcr-3' probe will identify the other end of the insertion which contains the 9q34/3'-BCR junction (3' junction) and the remainder of chromosome 22.
NotI-digested leukemic DNA showed a 340-kb rearranged fragment that hybridized with M-bcr-3' and the 0.4-kb BamHI probe (Fig 4A) . Calculations based on a previously published long-range map of BCR indicate that most of this abnormal 340-kb NotI fragment derives from chromosome 22 sequences distal to 3' M-bcr; approximately 28 kb may derive from the 3' part of the 9q34 insertion" (Fig  2C and D) .
Hybridization of the same filter with the ABL exon IB and T-39-2-2 probes showed germline NotI and S ' I fragment sizes only, indicating that the first ABL intron was intact, as was the 75-kb segment immediately upstream of ABL (Figs  2 A and B and 4) . The T-39-1-2 probe showed germline NotI fragments and a rearranged 275-kb S ' I band (Fig 4) . This result suggested that a breakpoint in ABL had occurred in the second intron between exon IA and the first common exon I1 (Fig 2A and B) . M-bcr-5' detected a 75-kb rearranged S ' I fragment, which also hybridized to a 3' ABL probe (ABL exon 111) ( Fig  4B) . Because an S ' I site exists 3 kb 5' of the M-bcr breakpoint, 72 kb of the rearranged fragment must derive from the 3' ABL region (Fig 2C and D) . This places the breakpoint in ABL close to exon IA, a location consistent with that which we found using the 5' ABL probes (Fig 2) . A rearranged ~4 5 0 -k b NotI fragment was detected by the ABL exon Ill probe (Fig 4A) . The M-bcr-5' probe hybridized to a single fragment of this size in both patient and control DNA. Because our patient's leukemic cells lack germline M-BCR alleles, however, we concluded that the ~4 5 0 -k b M-bcr-5' fragment in his DNA was actually rearranged and cohybridized with the ABL exon I11 probe.
Previous reports28 have placed a germline NotI site 150 kb 5' of M-bcr on chromosome 22 (Fig 2C) . If we assume that this 5' region is not rearranged in our patient, the remaining 2300 kb of the rearranged 2450-kb NotI fragment must derive from ABL and from sequences 3' of ABL to the next most 3'NotI site on chromosome 9 (Fig 2A, C, and D) . When regions containing ABL sequences and the sequences 3' of ABL on 9q34 are combined, we estimate that a minimum of 329 kb of chromosome 9 DNA is inserted into BCR on chromosome 22 (Fig 2D) .
DISCUSSION
We wished to determine the size of chromosome 9 insert and features of its 5' and 3'junctions with the BCR gene. We know that the breakpoint in M-BCR occurred within the BamHI-XhoZ fragment, which includes the third exon of M-BCR, a breakpoint site that is conventional for the standard t(9;22). 30 We assumed for our experimental model that these broken ends of M-BCR represented the two junctions of the chromosome 9 insert. FIGE studies showed that the 5'junction required a breakpoint in ABL between exon 1A and exon 2, again a conventional breakpoint for the standard t(9;22). 30 We conclude that the 5'junction of BCR and ABL was typical of those described for other patients with CML; this emphasizes the precise association of 5' BCR and ABL sequences, within a latitude allowed by messenger splicing, as we might expect for proper functioning of the fusion gene.
The 3'junction, on the contrary, is distinct from any in the standard t(9;22), where BCR-3' is joined to 5' ABL sequences on the 9q+ derivative chromosome (Fig 2) .6.27328 Using the M-bcr-3' probe as a starting point to investigate the chromosome 9 sequences adjacent to BCR-3', we isolated a 9.5-kb 3' junction fragment. An 0.4-kb BamHI probe isolated 5' of the breakpoint characterized an 8-kb region of chromosome 9q34 lying 3' of ABL and rich in unidentified repetitive sequences. The chromosome 9 insert into the BCR gene on chromosome 22 was at least 329 kb long and encompassed those 3' ABL sequences important for leukemia and also a larger portion of chromosome 9 distal to the ABL gene.
The BCR-ABL fusion gene arises in most patients in whom CML or any leukemia of the Ph group develops, as a consequence of cytogenetic translocation, most commonly the t(9;22)(q34;qll). The presence of the fusion gene in Ph-negative leukemia can be explained by cytogenetic mechanisms that are merely variants of the usual t(9;22). The apparently normal karyotype of our patient could have arisen by a standard t(9;22)(q34;qll) followed by a second translocation between the derivative 9 and 22 chromosomes that reversed the original translocation and reconstituted chromosome 22, leaving in it the chromosome 9 insert containing ABL (Fig 5A) . In that event, the reconstituting breakpoint in the derivative chromosome 9 occurred at, or close to, the site of the earlier union of ABL-5' and M-BCR-3' (Fig 5A) . The breakpoint was not 5' of that site because our FIGE studies showed no association of ABL-5' and M-bcr-3', and the breakpoint was not 3' of that site because our earlier in situ hybridization results showed M-Bcr-3' to be present on the reconstituted chromosome 22 rather than the derivative 9 chromosome." The reconstituting breakpoint in the derivative chromosome 22 occurred 3' of ABL within 9q34 ( Fig  5A) .
Other researchers have suggested that Ph-negative CML showing BCR rearrangement arises from reconstitution of the standard t(9;22), and there is clear evidence for this in one case.""'.32 Using genomic markers, we demonstrated For personal use only. on September 24, 2017. by guest www.bloodjournal.org From * -jthat the apparently normal karyotype in the leukemic cells of another patient with Ph-negative, BCR-rearranged C M L arose from a standard t(9;22), which was followed by a complex three-way rearrangement between the derivative 9 and 22 chromosomes and chromosome 20. 33 The genomic rearrangement in the leukemic cells of our present patient fits the reconstitution model but, alternatively, it may have resulted from a single cytogenetic event involving a two-break deletion of chromosome 9q34, including ABL, and its insertion between the ends of a single breakpoint within M-BCR (Fig SB) . We cannot distinguish between this mechanism and one involving two translocations.
Although our studies do not indicate a precise mechanism by which ABL was inserted within the BCR gene in Ph-negative CML, they do allow us to exclude some possible mechanisms. The most intriguing of these concerned the movement of ABL by some transposon mechanism, perhaps mediated by retroviruses. Such action is rare in humans, but is a usual mode of oncogene transmission in experimental animals. Our findings clearly exclude any such mechanism. The chromosome 9 insert including ABL sequences was more than 300 kb long and of greater size than sequences that are moved by transposon mechanisms. FIGE studies of leukemic DNA showed dimensions consistent with genomic ABL; we showed previously that the leukemic ABL has retained intron sequences: These data exclude any involvement of an R N A intermediate.
The 0.4-kb BumHI probe from 9q34 will be useful in analyzing regions 3' of ABL in other leukemias. We showed that segments containing this probe site were not rearranged in conventionally restricted leukemic cell DNA of three other patients with Ph-negative C M L who had normal karyotypes and rearranged BCR. The 3'junction appears to occur at different chromosome 9 sites in different patients. This finding might argue against the presence of "recombinant" sites on 9q34 that favored reconstitution of (9;22) translocations unless several of these sites, possibly associated with similar repetitive sequences, were distributed over a wide region of 9q34 telomeric of ABL. FIGE analysis of other Ph-negative patients using the 0.4-kb BamHI probe should clarify this question.
